Technologies

Bioxytran CEO David Platt, Ph.D. to Present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference

  • by

Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company focused on the development of novel carbohydrate-based therapeutics, today announced that David Platt, Ph.D., Chief Executive Officer of Bioxytran, will present at Noble Capital Markets’ Emerging Growth… Read More »Bioxytran CEO David Platt, Ph.D. to Present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference